Ceftaroline pharmacokinetics on ECMO, a pediatric case report.

Int J Antimicrob AgentsJun 26, 2026 (epub)
Case ReportPediatricsInfectious DiseasesOpen access

Kathryn Pavia, Ashton Bellamy, Alaina Burns et al.

✦ AI-curated · Sources linked

Case in brief

A 5-year-old patient on ECMO for influenza-associated necrotizing pneumonia was analyzed for ceftaroline pharmacokinetics. Nine concentrations were measured, revealing minimal changes in volume of distribution and clearance post-cannulation. The patient maintained 100%-time above MIC while on ECMO, indicating effective ceftaroline exposure without significant adsorption in the oxygenator circuit.

Diagnostic / clinical pearl

Clinicians should note that ceftaroline can achieve therapeutic concentrations in pediatric patients on ECMO, suggesting its continued use may be viable in this setting.

Why it matters

This case highlights the potential for effective antibiotic therapy in ECMO patients, addressing concerns about drug sequestration and supporting treatment decisions in similar clinical scenarios.

Source

Published in Int J Antimicrob Agents. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.